Stay updated with breaking news from Bill Rote. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good day and welcome to the Travere Therapeutics Fourth Quarter and Full Year 2023 Financial Results and Corporate Update Conference Call. Today's conference is being recorded.
Operator: Good day, and welcome to the Travere Therapeutics Third Quarter 2023 Financial Results and Corporate Update Conference Call. Today's conference call is being recorded.
Operator: Good day, and welcome to the Travere Therapeutics First Quarter 2023 Financial Results and Corporate Update Conference Call. Today's conference is being recorded.
RARE-X Announces Patient Community Data Collection, Sharing, and Platform Enhancements Share Article Further development of data standards and governance, as well as additional case testing, is made possible through support from Travere Therapeutics “We are excited to support RARE-X, who shares our goal of elevating science and service for people living with rare disease,” said Bill Rote, Ph.D., senior vice president of research and development at Travere Therapeutics. ALISO VIEJO, Calif. (PRWEB) February 23, 2021 RARE-X tod...